BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
Bio-Techne (NASDAQ: TECH) has announced its participation in the Citi 2024 Global Healthcare Conference. Kim Kelderman, President and Chief Executive Officer, will deliver a presentation on Wednesday, December 4, 2024, at 3:15 p.m. EST. Interested parties can access a live webcast of the presentation through the IR Calendar page on Bio-Techne's Investor Relations website.
Bio-Techne (NASDAQ: TECH) ha annunciato la sua partecipazione alla Conferenza Globale sulla Salute 2024 di Citi. Kim Kelderman, Presidente e Amministratore Delegato, terrà una presentazione mercoledì 4 dicembre 2024, alle 15:15 EST. Le parti interessate possono accedere a una diretta web della presentazione attraverso la pagina del Calendario IR sul sito delle Relazioni con gli Investitori di Bio-Techne.
Bio-Techne (NASDAQ: TECH) ha anunciado su participación en la Conferencia Global de Salud 2024 de Citi. Kim Kelderman, Presidente y Director Ejecutivo, realizará una presentación el miércoles 4 de diciembre de 2024, a las 3:15 p.m. EST. Las partes interesadas pueden acceder a una transmisión en vivo de la presentación a través de la página del Calendario IR en el sitio web de Relaciones con Inversores de Bio-Techne.
Bio-Techne (NASDAQ: TECH)가 Citi 2024 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. Kim Kelderman 사장 겸 CEO가 2024년 12월 4일 수요일 오후 3시 15분(EST)에 발표를 할 예정입니다. 관심 있는 분들은 Bio-Techne의 투자자 관계 웹사이트에 있는 IR 캘린더 페이지를 통해 발표의 실시간 웹캐스트에 접속할 수 있습니다.
Bio-Techne (NASDAQ: TECH) a annoncé sa participation à la Conférence Mondiale sur la Santé 2024 de Citi. Kim Kelderman, Président et Directeur Général, fera une présentation le mercredi 4 décembre 2024, à 15h15 EST. Les parties intéressées peuvent accéder à un webinaire en direct de la présentation via la page du calendrier IR sur le site des Relations Investisseurs de Bio-Techne.
Bio-Techne (NASDAQ: TECH) hat seine Teilnahme an der Citi 2024 Global Healthcare Conference bekannt gegeben. Kim Kelderman, Präsident und CEO, wird am Mittwoch, dem 4. Dezember 2024, um 15:15 Uhr EST eine Präsentation halten. Interessierte Parteien können über die IR-Kalenderseite auf der Investor-Relations-Website von Bio-Techne auf einen Live-Stream der Präsentation zugreifen.
- None.
- None.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately
Contact: | David Clair, Vice President, Investor Relations & Corporate Development |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-citi-2024-global-healthcare-conference-302316680.html
SOURCE Bio-Techne Corporation
FAQ
When is Bio-Techne (TECH) presenting at the Citi 2024 Global Healthcare Conference?
How can I watch Bio-Techne's (TECH) presentation at the Citi Healthcare Conference?
Who will represent Bio-Techne (TECH) at the Citi 2024 Global Healthcare Conference?
